Old Web
English
Sign In
Acemap
>
Paper
>
PO-1825: Abiraterone sensitises response to high dose radiotherapy in prostate & bone cancer models in vitro.
PO-1825: Abiraterone sensitises response to high dose radiotherapy in prostate & bone cancer models in vitro.
2020
T. Wright
Kevin M. Prise
A. Cole
Keywords:
Bone cancer
Medicine
Oncology
Prostate
Abiraterone
Internal medicine
In vitro
Radiation therapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]